BRIDGE-DS study: evaluating the effectiveness and safety of dapagliflozin/sitagliptin combination in type 2 diabetes mellitus patients with heart failure

Cardiovascular Endocrinology & Metabolism · Published 2025-09-03 · DOI 10.1097/xce.0000000000000334

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1097/xce.0000000000000334

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists · Cardiovascular Endocrinology & Metabolism · 2023 · Same journal
• The interplay of heart rate variability and ventricular repolarization parameters in the obese state: a review · Cardiovascular Endocrinology & Metabolism · 2025 · Same journal
• Effects of obstructive sleep apnea on vascular structure and function in adults with obesity and type 2 diabetes: a comparative study · Cardiovascular Endocrinology & Metabolism · 2025 · Same journal
• Relationship between the triglyceride-glucose index and the SYNTAX score 2 in patients with non-ST elevation myocardial infarction · Cardiovascular Endocrinology & Metabolism · 2023 · Same journal
• The association between hypertension and different types of dietary carbohydrates · Cardiovascular Endocrinology & Metabolism · 2024 · Same journal
• Combined lactic acidosis and ketoacidosis in a female diabetic patient with severe heart failure · Cardiovascular Endocrinology & Metabolism · 2023 · Same journal
• Percutaneous coronary interventions in Sudan: insights from severely influenced conflict zone · Cardiovascular Endocrinology & Metabolism · 2025 · Same journal
• Cardiac autonomic neuropathy linked to left ventricular dysfunction in type 1 diabetic patients · Cardiovascular Endocrinology & Metabolism · 2022 · Same journal
• Pitavastatin-induced cholesterol deficiency elevates serum biomarkers associated with statin-related adverse effects in rats · Cardiovascular Endocrinology & Metabolism · 2025 · Same journal
• Trends in ischemic heart disease-related mortality in obese population in the United States · Cardiovascular Endocrinology & Metabolism · 2025 · Same journal